Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley H Appel

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Current Opinion in Neurology|July 27, 2018
Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesisJason R Thonhoff, Ericka P Simpson, Stanley H Appel
Expert Review of Proteomics|February 1, 2006
2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseasesEssam A Sheta, Stanley H Appel, Ira L Goldknopf
Trends in Immunology|November 3, 2009
T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?Stanley H Appel, David R Beers, Jenny S Henkel
Neurosurgery|November 15, 2005
Incidence and characteristics of spinal decompression surgery after the onset of symptoms of amyotrophic lateral sclerosisDaniel Yoshor, Arnett Klugh, Stanley H Appel, et al.
Muscle & Nerve|September 13, 2006
Predictability of disease progression in amyotrophic lateral sclerosisAdam Czaplinski, Albert A Yen, Ericka P Simpson, et al.
Archives of Neurology|August 16, 2006
Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?Adam Czaplinski, Albert A Yen, Ericka P Simpson, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|September 5, 2009
Microglia in ALS: the good, the bad, and the restingJenny S Henkel, David R Beers, Weihua Zhao, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 9, 2015
Protective and Toxic Neuroinflammation in Amyotrophic Lateral SclerosisKristopher G Hooten, David R Beers, Weihua Zhao, et al.
Molecular and Cellular Neurosciences|December 13, 2005
The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALSJenny S Henkel, David R Beers, László Siklós, et al.
Brain Pathology (Zurich, Switzerland)|November 27, 2023
Primary visual cortex pathology in ALS patients with C9ORF72 expansionMatthew D Cykowski, Anithachristy S Arumanayagam, Suzanne Z Powell, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Current Opinion in Neurology|July 27, 2018
Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesisJason R Thonhoff, Ericka P Simpson, Stanley H Appel
Expert Review of Proteomics|February 1, 2006
2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseasesEssam A Sheta, Stanley H Appel, Ira L Goldknopf
Trends in Immunology|November 3, 2009
T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?Stanley H Appel, David R Beers, Jenny S Henkel
Neurosurgery|November 15, 2005
Incidence and characteristics of spinal decompression surgery after the onset of symptoms of amyotrophic lateral sclerosisDaniel Yoshor, Arnett Klugh, Stanley H Appel, et al.
Muscle & Nerve|September 13, 2006
Predictability of disease progression in amyotrophic lateral sclerosisAdam Czaplinski, Albert A Yen, Ericka P Simpson, et al.
Archives of Neurology|August 16, 2006
Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?Adam Czaplinski, Albert A Yen, Ericka P Simpson, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|September 5, 2009
Microglia in ALS: the good, the bad, and the restingJenny S Henkel, David R Beers, Weihua Zhao, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 9, 2015
Protective and Toxic Neuroinflammation in Amyotrophic Lateral SclerosisKristopher G Hooten, David R Beers, Weihua Zhao, et al.
Molecular and Cellular Neurosciences|December 13, 2005
The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALSJenny S Henkel, David R Beers, László Siklós, et al.
Brain Pathology (Zurich, Switzerland)|November 27, 2023
Primary visual cortex pathology in ALS patients with C9ORF72 expansionMatthew D Cykowski, Anithachristy S Arumanayagam, Suzanne Z Powell, et al.
Pageof 10